1
/
of
0
Lezure (Levetiracetam)
Lezure (Levetiracetam)
Regular price
₱1,040.00 PHP
Regular price
Sale price
₱1,040.00 PHP
Taxes included.
Quantity
Couldn't load pickup availability
Lezure (Levetiracetam) is a prescription anticonvulsant medication used to manage seizures in patients with epilepsy. As a pyrrolidone derivative, levetiracetam works through a unique mechanism distinct from traditional anticonvulsants, binding to synaptic vesicle protein SV2A to reduce neuronal excitability and prevent seizure activity.
Levetiracetam is indicated for partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures in adults and pediatric patients. It is often prescribed as monotherapy or adjunctive therapy alongside other antiepileptic drugs, offering flexible dosing and rapid titration when clinically appropriate.
Key benefits include a favorable pharmacokinetic profile with minimal drug interactions, predictable linear kinetics, and renal elimination that simplifies dosage adjustments in patients with hepatic impairment. Unlike older anticonvulsants, levetiracetam does not require hepatic metabolism, making it suitable for polypharmacy in complex epilepsy management.
Lezure is available in multiple strengths and formulations to support individualized treatment plans. Common dosing ranges from 500 mg to 3,000 mg daily, divided into two doses, though clinical assessment determines optimal regimens.
Patients should take Lezure exactly as prescribed and report any unusual mood changes, behavioral effects, or adverse reactions to their healthcare provider. This medication is not a substitute for professional medical consultation and requires regular monitoring during treatment.
Consult your pharmacist or physician regarding interactions with other medications, pregnancy considerations, and contraindications before use.
Levetiracetam is indicated for partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures in adults and pediatric patients. It is often prescribed as monotherapy or adjunctive therapy alongside other antiepileptic drugs, offering flexible dosing and rapid titration when clinically appropriate.
Key benefits include a favorable pharmacokinetic profile with minimal drug interactions, predictable linear kinetics, and renal elimination that simplifies dosage adjustments in patients with hepatic impairment. Unlike older anticonvulsants, levetiracetam does not require hepatic metabolism, making it suitable for polypharmacy in complex epilepsy management.
Lezure is available in multiple strengths and formulations to support individualized treatment plans. Common dosing ranges from 500 mg to 3,000 mg daily, divided into two doses, though clinical assessment determines optimal regimens.
Patients should take Lezure exactly as prescribed and report any unusual mood changes, behavioral effects, or adverse reactions to their healthcare provider. This medication is not a substitute for professional medical consultation and requires regular monitoring during treatment.
Consult your pharmacist or physician regarding interactions with other medications, pregnancy considerations, and contraindications before use.